[[ type === 'moc' ? 'MARKET ON CLOSE' : 'FREE WEBINAR' ]]
[[ timeLabel ]] WATCH LIVE:
Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Jump-Start Your Search For Promising Trade Ideas With Barchart Premier’s "Top Stock Pick". FREE 30 Day Trial
Stocks | Futures | Watchlist | News | More
or
Faster, Cleaner, Better.

Danaher Corp (DHR)

Danaher Corp (DHR)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]] ([[ financialData.relativeStrengthDirection14d ]]) ([[ financialData.highPercent1y ]]) ([[ financialData.lowPercent1y ]])
Realtime quote and/or trades are not sourced from all markets.

Market News and Commentary

Is Thermo Fisher Scientific Stock Underperforming the S&P 500?

Valued at a market cap of $181.1 billion, Thermo Fisher Scientific Inc. (TMO) is a global provider of life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services, serving customers across North America, Europe, Asia-Pacific, and other international markets. It supports scientific research, drug development, clinical diagnostics, and laboratory operations worldwide.

Companies valued at $10 billion or more are generally classified as “large-cap” stocks, and Thermo Fisher Scientific fits this criterion perfectly. It operates through four business segments: Life Sciences Solutions; Analytical Instruments; Specialty Diagnostics; and Laboratory Products and Biopharma Services, offering a wide range of products and...

Fundamentals

See More
  • Market Capitalization, $K 129,288,528
  • Shares Outstanding, K 707,771
  • Annual Sales, $ 24,568 M
  • Annual Income, $ 3,614 M
  • EBIT $ 4,760 M
  • EBITDA $ 7,207 M
  • 60-Month Beta 0.81
  • Price/Sales 5.20
  • Price/Cash Flow 15.89
  • Price/Book 2.41

Options Overview Details

View History
  • Implied Volatility 32.98% (+0.46%)
  • Historical Volatility 28.98%
  • IV Percentile 77%
  • IV Rank 59.51%
  • IV High 40.44% on 10/01/25
  • IV Low 22.02% on 12/24/25
  • Expected Move (DTE 6) 5.77 (3.16%)
  • Put/Call Vol Ratio 0.27
  • Today's Volume 5,894
  • Volume Avg (30-Day) 6,101
  • Put/Call OI Ratio 0.91
  • Today's Open Interest 88,037
  • Open Int (30-Day) 84,303
  • Expected Range 176.90 to 188.44

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 22 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/26
See More
  • Average Estimate $1.85
  • Number of Estimates 9
  • High Estimate $1.95
  • Low Estimate $1.83
  • Prior Year $1.80
  • Growth Rate Est. (year over year) +2.78%

Price Performance

See More
Period Period Low Period High Performance
1-Month
160.93 +13.51%
on 05/15/26
184.32 -0.90%
on 05/29/26
+3.87 (+2.16%)
since 04/29/26
3-Month
160.93 +13.51%
on 05/15/26
208.01 -12.18%
on 03/02/26
-27.97 (-13.28%)
since 02/27/26
52-Week
160.93 +13.51%
on 05/15/26
242.80 -24.77%
on 01/22/26
-6.34 (-3.35%)
since 05/28/25

Most Recent Stories

More News
Is Thermo Fisher Scientific Stock Underperforming the S&P 500?

Despite Thermo Fisher Scientific's underperformance relative to the SPX over the past year, Wall Street analysts maintain a bullish outlook on the stock’s prospects.

$SPX : 7,580.06 (+0.22%)
TMO : 492.51 (+1.09%)
DHR : 182.67 (+1.13%)
Is Danaher Stock Underperforming the S&P 500?

Danaher has underperformed the S&P 500 over the past year, but analysts are highly optimistic about the stock’s prospects.

$SPX : 7,580.06 (+0.22%)
DHR : 182.67 (+1.13%)
RVTY : 104.55 (+3.29%)
Henry Schein Announces the Election of William K. “Dan” Daniel as Independent Chairman of the Board

Henry Schein, Inc. (Nasdaq: HSIC), the world’s largest provider of health care solutions to office-based dental and medical practitioners, today announced that its Board of Directors has elected William...

HSIC : 76.58 (+0.34%)
NVST : 23.55 (-0.51%)
DHR : 182.67 (+1.13%)
Research Tools & Consumables Stocks Q1 Results: Benchmarking Danaher (NYSE:DHR)

Research Tools & Consumables Stocks Q1 Results: Benchmarking Danaher (NYSE:DHR)

DHR : 182.67 (+1.13%)
Danaher Stock: Analyst Estimates & Ratings

Danaher has underperformed the broader market over the past year, but analysts are highly optimistic about the stock’s prospects.

$SPX : 7,580.06 (+0.22%)
HTEC : 34.83 (-0.30%)
DHR : 182.67 (+1.13%)
Danaher to Present at Bank of America Securities Healthcare Conference

WASHINGTON , May 6, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced that President and Chief Executive Officer, Rainer M. Blair, will be presenting at the Bank of America Securities...

DHR : 182.67 (+1.13%)
Danaher Announces Quarterly Dividend

WASHINGTON , May 5, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) announced today that its Board of Directors has approved a regular quarterly cash dividend of $0.40 per share of its common...

DHR : 182.67 (+1.13%)
Masimo Shareholders Approve Acquisition by Danaher

Masimo Corporation (Nasdaq: MASI) (“Masimo”), a leading global innovator in patient monitoring, today announced that its stockholders voted in favor of the proposal to adopt the previously announced...

MASI : 178.45 (unch)
DHR : 182.67 (+1.13%)
3 Profitable Stocks We’re Skeptical Of

3 Profitable Stocks We’re Skeptical Of

HUBG : 41.54 (-2.44%)
DDS : 590.21 (-3.03%)
DHR : 182.67 (+1.13%)
Danaher Announces Pricing of Euro-Denominated Senior Notes Offering

WASHINGTON , April 22, 2026 /PRNewswire/ -- Danaher Corporation (NYSE: DHR) ("Danaher") announced today that it has priced an offering of the following euro-denominated senior notes (the "Offering"):...

DHR : 182.67 (+1.13%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 64% Sell with a Weakest short term outlook on maintaining the current direction.

Long term indicators fully support a continuation of the trend.

See More Share

Business Summary

Danaher Corporation is a global conglomerate that designs, manufactures and markets diverse lines of professional, industrial, commercial and consumer products. The company's segmental details are provided below: Life Sciences segment offers a broad range of research tools used to analyze a range of...

See More

Key Turning Points

3rd Resistance Point 189.96
2nd Resistance Point 187.14
1st Resistance Point 184.91
Last Price 182.67
1st Support Level 179.85
2nd Support Level 177.03
3rd Support Level 174.80

See More

52-Week High 242.80
Fibonacci 61.8% 211.53
Fibonacci 50% 201.86
Fibonacci 38.2% 192.20
Last Price 182.67
52-Week Low 160.93

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.
Use your up/down arrows to move through the symbols.